Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus

The objective of the study was to identify different phenotypes of overweight in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) based on body mass index (BMI) and serum leptin levels, as well as to determine the frequencies of various metabolic disorders, hypertension, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Doklady. Biochemistry and biophysics 2024-08, Vol.517 (1), p.182-194
Hauptverfasser: Kondratyeva, L.V., Gorbunova, Yu. N., Panafidina, T. A., Popkova, T. V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 194
container_issue 1
container_start_page 182
container_title Doklady. Biochemistry and biophysics
container_volume 517
creator Kondratyeva, L.V.
Gorbunova, Yu. N.
Panafidina, T. A.
Popkova, T. V.
description The objective of the study was to identify different phenotypes of overweight in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) based on body mass index (BMI) and serum leptin levels, as well as to determine the frequencies of various metabolic disorders, hypertension, and cardiovascular complications (CVCs) in individual phenotypes. The study included 50 women with RA and 46 with SLE aged 18 to 65 years without a history of diabetes and fasting hyperglycemia. In all patients, the concentration of leptin was determined by ELISA, the concentration of insulin was determined by electrochemiluminescence analysis, and the HOMA-IR index was calculated. Hyperleptinemia was diagnosed at leptin concentrations > 11.1 ng/mL; insulin resistance (IR), at HOMA-IR values ≥ 2.77. Three main phenotypes of overweight were distinguished: “classic” (BMI ≥ 25 kg/m 2 + hyperleptinemia), “healthy” (BMI ≥ 25 kg/m 2 , without hyperleptinemia), “hidden” or “latent” (BMI < 25 kg/m 2 + hyperleptinemia), as well as “normal weight” (BMI < 25 kg/m 2 , without hyperleptinemia). Patients with RA and SLE were similar in age ( p = 0.4), disease duration ( p = 0.2) and BMI ( p = 0.5). Hyperleptinemia was found in 46% of women with RA and in 74% of women with SLE ( p = 0.005), and IR was found in 10 and 22% of patients, respectively ( p = 0.2). The “classic” phenotype of overweight was diagnosed in 30%, “healthy” in 8%, and “hidden” in 16% of cases with RA and in 44%, 0%, and 30% of cases with SLE, respectively. IR was found in 3% and hypertension in 6% of patients with “normal weight.” With the “classic” phenotype, IR (29%) and hypertension (66%) were more common than with “normal weight” ( p < 0.01 in all cases); with the “hidden” phenotype, significant differences were obtained only in hypertension frequency (45%; p = 0.0012), but not IR (18%). Three out of four women with a history of cardiovascular complications suffered from “classic” overweight, and one patient had a “normal weight.” In women with SLE up to 65 years of age, the frequency of hyperleptinemia, but not IR, is higher than in patients with RA. In both diseases, the “classic” overweight phenotype is most common. In RA, a “hidden” phenotype was detected less often than in SLE, at the same time, a “healthy” phenotype is not characteristic of SLE. The frequency of metabolic disorders and hypertension is low with the “normal weight” and “healthy” phenotype, high with the “classic” phenotype, and inter
doi_str_mv 10.1134/S1607672924700893
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3066788939</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3083662389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c254t-b605270b873c546b42fa1bed067b5b50fc4a2d88aecb2f02c5ac8d195a4e5573</originalsourceid><addsrcrecordid>eNp1kctu1TAQhi0EoqXwAGyQJTZsAr7ElyyrqlCkg05FK1hGtjNpXE4u2A5VnoJXxulpiwTqytbM9_8z9o_Qa0reU8rLDxdUEiUVq1ipCNEVf4IOc0kXnFT06e1dFWv_AL2I8ZoQRhgXz9EB11pSWvJD9PtsmSDsYEp-gN4bbCI2-IsJPyDgscXfTPDjHPF5B8OYMhvX6tZC9GnBZmjw9heEG_BXXcJ-wN_HHgZ841OHv3Yw9yaNvsHHIXXBJx9vFRdLTHmWw5t5ytanYUkdrGSc40v0rDW7CK_uziN0-fH08uSs2Gw_fT453hSOiTIVVhLBFLFacSdKaUvWGmqhIVJZYQVpXWlYo7UBZ1lLmBPG6YZWwpQghOJH6N3edgrjzxliqnsfHex2ZoD83JoTKZXOP1pl9O0_6PU4hyEvlynNpWRcrxTdUy6MMQZo6yn43oSlpqRew6r_Cytr3tw5z7aH5kFxn04G2B6IuTVcQfg7-nHXP_kBoII</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3083662389</pqid></control><display><type>article</type><title>Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus</title><source>SpringerLink Journals - AutoHoldings</source><creator>Kondratyeva, L.V. ; Gorbunova, Yu. N. ; Panafidina, T. A. ; Popkova, T. V.</creator><creatorcontrib>Kondratyeva, L.V. ; Gorbunova, Yu. N. ; Panafidina, T. A. ; Popkova, T. V.</creatorcontrib><description>The objective of the study was to identify different phenotypes of overweight in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) based on body mass index (BMI) and serum leptin levels, as well as to determine the frequencies of various metabolic disorders, hypertension, and cardiovascular complications (CVCs) in individual phenotypes. The study included 50 women with RA and 46 with SLE aged 18 to 65 years without a history of diabetes and fasting hyperglycemia. In all patients, the concentration of leptin was determined by ELISA, the concentration of insulin was determined by electrochemiluminescence analysis, and the HOMA-IR index was calculated. Hyperleptinemia was diagnosed at leptin concentrations &gt; 11.1 ng/mL; insulin resistance (IR), at HOMA-IR values ≥ 2.77. Three main phenotypes of overweight were distinguished: “classic” (BMI ≥ 25 kg/m 2 + hyperleptinemia), “healthy” (BMI ≥ 25 kg/m 2 , without hyperleptinemia), “hidden” or “latent” (BMI &lt; 25 kg/m 2 + hyperleptinemia), as well as “normal weight” (BMI &lt; 25 kg/m 2 , without hyperleptinemia). Patients with RA and SLE were similar in age ( p = 0.4), disease duration ( p = 0.2) and BMI ( p = 0.5). Hyperleptinemia was found in 46% of women with RA and in 74% of women with SLE ( p = 0.005), and IR was found in 10 and 22% of patients, respectively ( p = 0.2). The “classic” phenotype of overweight was diagnosed in 30%, “healthy” in 8%, and “hidden” in 16% of cases with RA and in 44%, 0%, and 30% of cases with SLE, respectively. IR was found in 3% and hypertension in 6% of patients with “normal weight.” With the “classic” phenotype, IR (29%) and hypertension (66%) were more common than with “normal weight” ( p &lt; 0.01 in all cases); with the “hidden” phenotype, significant differences were obtained only in hypertension frequency (45%; p = 0.0012), but not IR (18%). Three out of four women with a history of cardiovascular complications suffered from “classic” overweight, and one patient had a “normal weight.” In women with SLE up to 65 years of age, the frequency of hyperleptinemia, but not IR, is higher than in patients with RA. In both diseases, the “classic” overweight phenotype is most common. In RA, a “hidden” phenotype was detected less often than in SLE, at the same time, a “healthy” phenotype is not characteristic of SLE. The frequency of metabolic disorders and hypertension is low with the “normal weight” and “healthy” phenotype, high with the “classic” phenotype, and intermediate with the “hidden” phenotype.</description><identifier>ISSN: 1607-6729</identifier><identifier>ISSN: 1608-3091</identifier><identifier>EISSN: 1608-3091</identifier><identifier>DOI: 10.1134/S1607672924700893</identifier><identifier>PMID: 38861143</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Biochemistry ; Biological and Medical Physics ; Biomedical and Life Sciences ; Biophysics ; Body mass index ; Body weight ; Diabetes mellitus ; Genotype &amp; phenotype ; Hyperglycemia ; Hypertension ; Insulin resistance ; Leptin ; Life Sciences ; Lupus ; Metabolic disorders ; Molecular Biology ; Overweight ; Phenotypes ; Rheumatoid arthritis ; Systemic lupus erythematosus</subject><ispartof>Doklady. Biochemistry and biophysics, 2024-08, Vol.517 (1), p.182-194</ispartof><rights>Pleiades Publishing, Ltd. 2024. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024, Vol. 517, pp. 182–194. © Pleiades Publishing, Ltd., 2024. ISSN 1607-6729, Doklady Biochemistry and Biophysics, 2024. © Pleiades Publishing, Ltd., 2024.</rights><rights>2024. Pleiades Publishing, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c254t-b605270b873c546b42fa1bed067b5b50fc4a2d88aecb2f02c5ac8d195a4e5573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1134/S1607672924700893$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1134/S1607672924700893$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38861143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kondratyeva, L.V.</creatorcontrib><creatorcontrib>Gorbunova, Yu. N.</creatorcontrib><creatorcontrib>Panafidina, T. A.</creatorcontrib><creatorcontrib>Popkova, T. V.</creatorcontrib><title>Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus</title><title>Doklady. Biochemistry and biophysics</title><addtitle>Dokl Biochem Biophys</addtitle><addtitle>Dokl Biochem Biophys</addtitle><description>The objective of the study was to identify different phenotypes of overweight in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) based on body mass index (BMI) and serum leptin levels, as well as to determine the frequencies of various metabolic disorders, hypertension, and cardiovascular complications (CVCs) in individual phenotypes. The study included 50 women with RA and 46 with SLE aged 18 to 65 years without a history of diabetes and fasting hyperglycemia. In all patients, the concentration of leptin was determined by ELISA, the concentration of insulin was determined by electrochemiluminescence analysis, and the HOMA-IR index was calculated. Hyperleptinemia was diagnosed at leptin concentrations &gt; 11.1 ng/mL; insulin resistance (IR), at HOMA-IR values ≥ 2.77. Three main phenotypes of overweight were distinguished: “classic” (BMI ≥ 25 kg/m 2 + hyperleptinemia), “healthy” (BMI ≥ 25 kg/m 2 , without hyperleptinemia), “hidden” or “latent” (BMI &lt; 25 kg/m 2 + hyperleptinemia), as well as “normal weight” (BMI &lt; 25 kg/m 2 , without hyperleptinemia). Patients with RA and SLE were similar in age ( p = 0.4), disease duration ( p = 0.2) and BMI ( p = 0.5). Hyperleptinemia was found in 46% of women with RA and in 74% of women with SLE ( p = 0.005), and IR was found in 10 and 22% of patients, respectively ( p = 0.2). The “classic” phenotype of overweight was diagnosed in 30%, “healthy” in 8%, and “hidden” in 16% of cases with RA and in 44%, 0%, and 30% of cases with SLE, respectively. IR was found in 3% and hypertension in 6% of patients with “normal weight.” With the “classic” phenotype, IR (29%) and hypertension (66%) were more common than with “normal weight” ( p &lt; 0.01 in all cases); with the “hidden” phenotype, significant differences were obtained only in hypertension frequency (45%; p = 0.0012), but not IR (18%). Three out of four women with a history of cardiovascular complications suffered from “classic” overweight, and one patient had a “normal weight.” In women with SLE up to 65 years of age, the frequency of hyperleptinemia, but not IR, is higher than in patients with RA. In both diseases, the “classic” overweight phenotype is most common. In RA, a “hidden” phenotype was detected less often than in SLE, at the same time, a “healthy” phenotype is not characteristic of SLE. The frequency of metabolic disorders and hypertension is low with the “normal weight” and “healthy” phenotype, high with the “classic” phenotype, and intermediate with the “hidden” phenotype.</description><subject>Biochemistry</subject><subject>Biological and Medical Physics</subject><subject>Biomedical and Life Sciences</subject><subject>Biophysics</subject><subject>Body mass index</subject><subject>Body weight</subject><subject>Diabetes mellitus</subject><subject>Genotype &amp; phenotype</subject><subject>Hyperglycemia</subject><subject>Hypertension</subject><subject>Insulin resistance</subject><subject>Leptin</subject><subject>Life Sciences</subject><subject>Lupus</subject><subject>Metabolic disorders</subject><subject>Molecular Biology</subject><subject>Overweight</subject><subject>Phenotypes</subject><subject>Rheumatoid arthritis</subject><subject>Systemic lupus erythematosus</subject><issn>1607-6729</issn><issn>1608-3091</issn><issn>1608-3091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kctu1TAQhi0EoqXwAGyQJTZsAr7ElyyrqlCkg05FK1hGtjNpXE4u2A5VnoJXxulpiwTqytbM9_8z9o_Qa0reU8rLDxdUEiUVq1ipCNEVf4IOc0kXnFT06e1dFWv_AL2I8ZoQRhgXz9EB11pSWvJD9PtsmSDsYEp-gN4bbCI2-IsJPyDgscXfTPDjHPF5B8OYMhvX6tZC9GnBZmjw9heEG_BXXcJ-wN_HHgZ841OHv3Yw9yaNvsHHIXXBJx9vFRdLTHmWw5t5ytanYUkdrGSc40v0rDW7CK_uziN0-fH08uSs2Gw_fT453hSOiTIVVhLBFLFacSdKaUvWGmqhIVJZYQVpXWlYo7UBZ1lLmBPG6YZWwpQghOJH6N3edgrjzxliqnsfHex2ZoD83JoTKZXOP1pl9O0_6PU4hyEvlynNpWRcrxTdUy6MMQZo6yn43oSlpqRew6r_Cytr3tw5z7aH5kFxn04G2B6IuTVcQfg7-nHXP_kBoII</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Kondratyeva, L.V.</creator><creator>Gorbunova, Yu. N.</creator><creator>Panafidina, T. A.</creator><creator>Popkova, T. V.</creator><general>Pleiades Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20240801</creationdate><title>Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus</title><author>Kondratyeva, L.V. ; Gorbunova, Yu. N. ; Panafidina, T. A. ; Popkova, T. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c254t-b605270b873c546b42fa1bed067b5b50fc4a2d88aecb2f02c5ac8d195a4e5573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biochemistry</topic><topic>Biological and Medical Physics</topic><topic>Biomedical and Life Sciences</topic><topic>Biophysics</topic><topic>Body mass index</topic><topic>Body weight</topic><topic>Diabetes mellitus</topic><topic>Genotype &amp; phenotype</topic><topic>Hyperglycemia</topic><topic>Hypertension</topic><topic>Insulin resistance</topic><topic>Leptin</topic><topic>Life Sciences</topic><topic>Lupus</topic><topic>Metabolic disorders</topic><topic>Molecular Biology</topic><topic>Overweight</topic><topic>Phenotypes</topic><topic>Rheumatoid arthritis</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kondratyeva, L.V.</creatorcontrib><creatorcontrib>Gorbunova, Yu. N.</creatorcontrib><creatorcontrib>Panafidina, T. A.</creatorcontrib><creatorcontrib>Popkova, T. V.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Doklady. Biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kondratyeva, L.V.</au><au>Gorbunova, Yu. N.</au><au>Panafidina, T. A.</au><au>Popkova, T. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus</atitle><jtitle>Doklady. Biochemistry and biophysics</jtitle><stitle>Dokl Biochem Biophys</stitle><addtitle>Dokl Biochem Biophys</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>517</volume><issue>1</issue><spage>182</spage><epage>194</epage><pages>182-194</pages><issn>1607-6729</issn><issn>1608-3091</issn><eissn>1608-3091</eissn><abstract>The objective of the study was to identify different phenotypes of overweight in women with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) based on body mass index (BMI) and serum leptin levels, as well as to determine the frequencies of various metabolic disorders, hypertension, and cardiovascular complications (CVCs) in individual phenotypes. The study included 50 women with RA and 46 with SLE aged 18 to 65 years without a history of diabetes and fasting hyperglycemia. In all patients, the concentration of leptin was determined by ELISA, the concentration of insulin was determined by electrochemiluminescence analysis, and the HOMA-IR index was calculated. Hyperleptinemia was diagnosed at leptin concentrations &gt; 11.1 ng/mL; insulin resistance (IR), at HOMA-IR values ≥ 2.77. Three main phenotypes of overweight were distinguished: “classic” (BMI ≥ 25 kg/m 2 + hyperleptinemia), “healthy” (BMI ≥ 25 kg/m 2 , without hyperleptinemia), “hidden” or “latent” (BMI &lt; 25 kg/m 2 + hyperleptinemia), as well as “normal weight” (BMI &lt; 25 kg/m 2 , without hyperleptinemia). Patients with RA and SLE were similar in age ( p = 0.4), disease duration ( p = 0.2) and BMI ( p = 0.5). Hyperleptinemia was found in 46% of women with RA and in 74% of women with SLE ( p = 0.005), and IR was found in 10 and 22% of patients, respectively ( p = 0.2). The “classic” phenotype of overweight was diagnosed in 30%, “healthy” in 8%, and “hidden” in 16% of cases with RA and in 44%, 0%, and 30% of cases with SLE, respectively. IR was found in 3% and hypertension in 6% of patients with “normal weight.” With the “classic” phenotype, IR (29%) and hypertension (66%) were more common than with “normal weight” ( p &lt; 0.01 in all cases); with the “hidden” phenotype, significant differences were obtained only in hypertension frequency (45%; p = 0.0012), but not IR (18%). Three out of four women with a history of cardiovascular complications suffered from “classic” overweight, and one patient had a “normal weight.” In women with SLE up to 65 years of age, the frequency of hyperleptinemia, but not IR, is higher than in patients with RA. In both diseases, the “classic” overweight phenotype is most common. In RA, a “hidden” phenotype was detected less often than in SLE, at the same time, a “healthy” phenotype is not characteristic of SLE. The frequency of metabolic disorders and hypertension is low with the “normal weight” and “healthy” phenotype, high with the “classic” phenotype, and intermediate with the “hidden” phenotype.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><pmid>38861143</pmid><doi>10.1134/S1607672924700893</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1607-6729
ispartof Doklady. Biochemistry and biophysics, 2024-08, Vol.517 (1), p.182-194
issn 1607-6729
1608-3091
1608-3091
language eng
recordid cdi_proquest_miscellaneous_3066788939
source SpringerLink Journals - AutoHoldings
subjects Biochemistry
Biological and Medical Physics
Biomedical and Life Sciences
Biophysics
Body mass index
Body weight
Diabetes mellitus
Genotype & phenotype
Hyperglycemia
Hypertension
Insulin resistance
Leptin
Life Sciences
Lupus
Metabolic disorders
Molecular Biology
Overweight
Phenotypes
Rheumatoid arthritis
Systemic lupus erythematosus
title Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T21%3A28%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperleptinemia%20as%20a%20Marker%20of%20Various%20Phenotypes%20of%20Obesity%20and%20Overweight%20in%20Women%20with%20Rheumatoid%20Arthritis%20and%20Systemic%20Lupus%20Erythematosus&rft.jtitle=Doklady.%20Biochemistry%20and%20biophysics&rft.au=Kondratyeva,%20L.V.&rft.date=2024-08-01&rft.volume=517&rft.issue=1&rft.spage=182&rft.epage=194&rft.pages=182-194&rft.issn=1607-6729&rft.eissn=1608-3091&rft_id=info:doi/10.1134/S1607672924700893&rft_dat=%3Cproquest_cross%3E3083662389%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3083662389&rft_id=info:pmid/38861143&rfr_iscdi=true